treatment of bacterial keratitis

Esculentin 1a derived peptides for treatment of microbial keratitis

We discovered that Esc peptides are highly efficient in reducing the level of infection in a mouse model of keratitis upon local administration in a drop-wise fashion. Our current aim is the development of our peptides as new ophthalmic agents for treatment of bacterial keratitis, as well as to produce antimicrobial contact lenses for preventative …

Esculentin 1a derived peptides for treatment of microbial keratitis Read More »